BIO RAD LABS INC (BIOB)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
4
Reporting holders
$315.9K
Reported value
0.0%
Held as options
-2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| MORGAN STANLEY | $214.3K | 712 | 0.00% | 29q | HELD |
| WELLS FARGO & COMPANY/MN | $50.4K | 170 | 0.00% | 31q | -50.0%-$50.4K |
| WHITTIER TRUST CO | $47.3K | 160 | 0.00% | 16q | HELD |
| UBS Group AG | $3.9K | 13 | 0.00% | 3q | HELD |
| FLOW TRADERS U.S. LLC | $229 | 760 | 0.01% | 2q | -22.8% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 4 | $315.9K | 1,055 | 0 | 0 | 1 | 0.0% |
| Q1 2026 | 6 | $823.6K | 2,962 | 0 | 3 | 1 | 0.0% |
| Q4 2025 | 6 | $860.9K | 2,833 | 1 | 0 | 2 | 0.0% |
| Q3 2025 | 5 | $809.5K | 2,894 | 1 | 0 | 0 | 0.0% |
| Q2 2025 | 5 | $520.4K | 2,137 | 0 | 1 | 0 | 0.0% |
| Q1 2025 | 5 | $518.4K | 2,135 | 0 | 0 | 1 | 0.0% |
| Q4 2024 | 8 | $1.3M | 4,069 | 2 | 1 | 1 | 0.0% |
| Q3 2024 | 6 | $1.1M | 3,332 | 1 | 1 | 1 | 0.0% |
| Q2 2024 | 8 | $935.1K | 3,445 | 1 | 0 | 2 | 0.0% |
| Q1 2024 | 7 | $1.7M | 5,104 | 1 | 1 | 0 | 0.0% |
| Q4 2023 | 6 | $1.4M | 4,351 | 0 | 1 | 1 | 0.0% |
| Q3 2023 | 7 | $1.3M | 3,713 | 1 | 0 | 0 | 0.0% |
| Q2 2023 | 6 | $1.4M | 3,711 | 0 | 1 | 0 | 0.0% |
| Q1 2023 | 8 | $1.9M | 4,034 | 1 | 0 | 0 | 0.0% |
| Q4 2022 | 7 | $1.5M | 3,633 | 1 | 1 | 0 | 0.0% |
| Q3 2022 | 7 | $2.2M | 5,295 | 1 | 0 | 0 | 0.0% |
| Q2 2022 | 8 | $2.7M | 5,662 | 3 | 2 | 1 | 0.0% |
| Q1 2022 | 7 | $2.9M | 5,023 | 1 | 0 | 2 | 0.0% |
| Q4 2021 | 12 | $82.7M | 109,603 | 0 | 2 | 2 | 0.0% |
| Q3 2021 | 12 | $82.3M | 110,301 | 2 | 1 | 0 | 0.0% |
| Q2 2021 | 10 | $70.6M | 109,626 | 2 | 0 | 1 | 0.0% |
| Q1 2021 | 10 | $10.3M | 17,973 | 4 | 0 | 2 | 0.0% |
| Q4 2020 | 6 | $6.6M | 11,373 | 0 | 0 | 2 | 0.0% |
| Q3 2020 | 7 | $9.2M | 17,989 | 2 | 2 | 1 | 0.0% |
| Q2 2020 | 6 | $7.8M | 17,459 | 0 | 3 | 0 | 0.0% |
| Q1 2020 | 6 | $5.7M | 16,266 | 0 | 1 | 1 | 0.0% |
| Q4 2019 | 8 | $6.8M | 18,390 | 1 | 1 | 1 | 0.0% |
| Q3 2019 | 8 | $9.0M | 26,573 | 1 | 1 | 1 | 0.0% |
| Q2 2019 | 7 | $8.2M | 26,427 | 1 | 0 | 0 | 0.0% |
| Q1 2019 | 6 | $7.9M | 25,905 | 0 | 0 | 1 | 0.0% |
| Q4 2018 | 7 | $6.1M | 26,693 | 0 | 0 | 1 | 0.0% |